The role of radiotherapy in local and advanced stages of nodal non-Hodgkin's lymphoma;Stellenwert der strahlentherapie bei nodalen non-Hodgkin-lymphomen in lokalen und fortgeschrittenen stadien

Onkologe

Volumn 7, Issue 9, 2001, Pages 960-968

  Schmidberger, H ^a   Hess, C F ^a   Rube Ch ^b  

^a Klinik und Poliklinik für Psychiatrie und Psychotherapie   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; NONHODGKIN LYMPHOMA; REVIEW;

EID: 0034798370     PISSN: 09478965     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007610170044     Document Type: Review

References (41)

1. High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: Long-term clinical and molecular follow-up
2. Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma
3. Dose-effect relations for local functional and structural changes of the lung after irradiation for malignant lymphoma
4. Combined radiotherapy-chemotherapy for early stages non-Hodgkinís lymphoma: The 1975-1980 EORTC controlled lymphoma trial
5. Superiority of second over first generation chemotherapy in a randomized trial for stage III-IV intermediate and high grade non-Hodgkin's lymphoma (NHL): The 1980-1985 EORTC trial
6. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
7. Complications from large field intermediate dose infradiaphragmatic radiation: An analysis of the patterns of care outcome studies for Hodgkinís disease and seminoma
8. Central lymphatic irradiation to low dose advanced nodular lymphoreticular tumors (non-Hodgkin's lymphoma)
9. Prospective multicenter trial for the response-adapted treatment of high grade malignant non-Hodgkin's lymphomas. Updated results of the COP-BLAMIIMVP-16 protocol with randomized adjuvant radiotherapy
10. Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma
11. Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma
12. Recurrence rates following therapy of nodular and diffuse malignant lymphomas
13. Strahlentherapie bei non-Hodgkin-lymphomen
14. Long-term follow up and analysis for prognostic factors for patients with limited stage large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy
15. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in Stage I and II non-Hodgkin's lymphoma
16. Curative radiotherapy for localized diffuse histiocytic lymphoma
17. Second malignant neoplasm in patients with non-Hodgkin's lymphoma
18. Is radiotherapy curative for stage I or II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University
19. What is the prognosis for patients who relapse after primary radiation therapy for early-stage low-grade follicular lymphoma?
20. Salvage extended-field irradiation in follicular non-Hodgkin's lymphoma after failure of chemotherapy
21. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate-and high-grade non-Hodgkin's lymphoma
22. Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkinís lymphoma
23. Long-term follow-up of patients with stage III follicular lymphoma treated primary radiotherapy at Stanford university
24. Treatment for non-Hodgkin's lymphoma (stage I, II) of the elderly: Usefulness of local and regional irradiation and reduced dose chemotherapy
25. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma
26. Place of low-dose total body irradiation in the treatment of localized follicular non-Hodgkin's lymphoma: Results of a pilot study
27. Consolidation radiotherapy to bulky disease in aggressive NHL. First results of the NHL B-94 trial of the DSHNHL
28. The role of low-dose total body irradiation in treatment of non-Hodgkin's lymphoma: A new look at an old method
29. Low dose palliative radiotherapy in low grade non-Hodgkin's lymphoma
30. Extended field and total central lymphatic radiotherapy in the treatment of early stage lymph node centroblastic-centrocytic lymphomas
31. Role of radiation therapy in localized non-Hodgkin's lymphoma
32. Survival of patients with localized diffuse histiocytic lymphoma
33. Influence of therapy on local control and survival in stage I and II intermediate and high grade non-Hodgkinís lymphoma
34. Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkinís lymphomas
35. Intensification of the CHOEP regimen for high-grade non-Hodgkin's lymphoma by G-CSF: Feasibility of a 15-day regimen
36. Sequencing of drugs and radiation
37. Prognostic factors in non-Hodgkinís lymphoma
38. Clinical stage I non-Hodgkinís lymphoma: Long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy
39. Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas
40. Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy
41. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of Cyclophosphamide, Doxorubicin, Vincristine an Prednisone with or without radiotherapy for aggressive lymphoma